In vitro amplification adjustable T cell method

An in vitro amplification and regulatory technology, applied in the field of biomedicine, can solve the problems of inability to achieve tolerance, prolong the survival of allografts, lack of immunosuppressive function, etc., and achieve the effect of sufficient quantity and great clinical application value

Inactive Publication Date: 2009-12-16
吕凌
View PDF0 Cites 22 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Such as: (1) Blocking co-stimulatory pathways: Although in transplanted animal models, the survival time of allografts can be significantly prolonged by blocking co-stimulatory pathways, but this method cannot achieve sustained and stable tolerance
(2) Immature allogeneic dendritic cells (DC): At present, immature DC induced in vitro can induce antigen-specific T cel

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • In vitro amplification adjustable T cell method
  • In vitro amplification adjustable T cell method
  • In vitro amplification adjustable T cell method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Materials: CD4+ T cell isolation kit (purchased from Miltenyi Biotec, USA), anti-human CD3 (BD ​​Com., USA) coated culture plate (purchased from VWR, USA), systemic immunodeficiency (SCID) mice (purchased from Jackson Laboratory, USA).

[0031] Instruments: magnetic bead separator (Auto MACS from Miltenyi, Germany), flow cytometer (BD company, model: Vantage SE).

[0032] Reagent: Inducer: anti-CD3CD28-beads (the ratio of cells to cells is 1:10, Invitrogen), rhIL-2 (final concentration after addition is 100IU / mL), rhTGF-β (final concentration after addition is 5ng / mL) Purchased from BD Company of the United States and Rapamycin (final concentration after adding was 10nM) was purchased from Wyeth Pharmaceuticals. Amplifier: rhIL-2 (20IU / mL), anti-humanCD28 (1ng / ml), Rapamycin (10nM, Wyeth Pharmaceuticals); culture medium was supplemented with 100U / ml penicillin in complete RPMI-1640 medium, 100μg / ml chain Mycin, 2mM L-glutamic acid, 10mM 4-hydroxyethylpiperazineethanes...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for amplifying cells, in particular to an in vitro amplification adjustable T cell method, belonging to the technical field of biomedical science. The invention uses Rapamycin combined with TGF-beta to induce human T cell in vitro to become adjustable T cell having immune suppression function, having the following advantages in : 1. enough quantity; and 2. capability of resisting differentiation towards Th 17 cell. The invention overcomes plural defects of natural adjustable T cell, and has larger curing advantages in curing inflammation diseases, autoimmune diseases and prevention of immunity rejection of organ implantation.

Description

technical field [0001] The invention relates to a method for expanding cells, in particular to a method for expanding regulatory T cells in vitro, and belongs to the technical field of biomedicine. Background technique [0002] For nearly half a century, while immunosuppressive drugs have significantly prolonged the survival time of allografts, they also have a series of serious problems due to their own toxic side effects, high prices, and clinical complications caused by drug-induced non-specific immunosuppression. , greatly restricting the further development of clinical organ transplantation. It has become one of the basic topics in the field of transplantation immunology to reduce or even eliminate immunosuppressants by inducing graft-specific immune tolerance or achieving a "clinically almost tolerated" state similar to the application of immunosuppressants. Although many investigators have successfully induced a state of immune tolerance in allografts in different an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/08
Inventor 吕凌张峰王学浩
Owner 吕凌
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap